Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
Think pertussis! Maternal and on-time infant vaccinations are essential
+Practice
In print
VACCINES
Think pertussis! Maternal and on-time infant vaccinations are essential
Wednesday 12 April 2023, 12:15 AM

Pertussis immunisation rates in pregnancy, Auckland, by ethnicity [Image: UC GeoHealth, geohealthlab.shinyapps.io/hapumama]
Aotearoa is likely to be on the verge of a pertussis outbreak with recently reported cases just the tip of the iceberg – are you and your patients ready?
Key points, The next pertussis epidemic is coming, and infants are most vulnerable to severe disease and death.
Pregnancy vaccinations and on-time infant primar, Pract Green w Pale Yellow
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References
- Amirthalingam G, Campbell H, Ribeiro S, et al. Sustained effectiveness of the maternal pertussis immunization program in England 3 years following introduction. Clin Infect Dis 2016;63(Suppl. 4):S236–43.
- Bechini A, Tiscione E, Boccalini S, et al. Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): a review of evidence and recommendations. Vaccine 2012;30(35):5179–90.
- Howe AS, Pointon L, Gauld N, et al. Pertussis and influenza immunisation coverage of pregnant women in New Zealand. Vaccine 2020;38(43):6766–76.
- Melvin J, Scheller E, Miller J, et al. Bordetella pertussis pathogenesis: current and future challenges. Nat Rev Microbiol 2014;12:274–88.
- Petousis-Harris H, Jiang Y, Yu L, et al. A retrospective cohort study of safety outcomes in New Zealand infants exposed to Tdap vaccine in utero. Vaccines (Basel) 2019;7(4):147.
- Radke S, Petousis-Harris H, Watson D, et al. Age-specific effectiveness following each dose of acellular pertussis vaccine among infants and children in New Zealand. Vaccine 2017;35(1):177–83.
- Sukumaran L, McCarthy NL, Kharbanda EO, et al. Association of Tdap vaccination with acute events and adverse birth outcomes among pregnancy women with prior tetanus-containing immunizations. JAMA 2015;314(15):1581–87.
- Wendelboe AM, Njamkepo E, Bourillon A, et al. Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J 2007;26(4):293–99.
- Wiley KE, Zuo Y, Macartney KK, McIntyre PB. Sources of pertussis infection in young infants: a review of key evidence informing targeting of the cocoon strategy. Vaccine 2013;31(4):618–25.